Annual Total Debt:
$638.85M+$52.81M(+9.01%)Summary
- As of today (July 1, 2025), PCRX annual total debt is $638.85 million, with the most recent change of +$52.81 million (+9.01%) on December 31, 2024.
- During the last 3 years, PCRX annual total debt has fallen by -$490.00 million (-43.41%).
- PCRX annual total debt is now -43.41% below its all-time high of $1.13 billion, reached on December 31, 2021.
Performance
PCRX Total debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Debt:
$636.46M-$2.39M(-0.37%)Summary
- As of today (July 1, 2025), PCRX quarterly total debt is $636.46 million, with the most recent change of -$2.39 million (-0.37%) on March 31, 2025.
- Over the past year, PCRX quarterly total debt has increased by +$54.68 million (+9.40%).
- PCRX quarterly total debt is now -43.62% below its all-time high of $1.13 billion, reached on December 31, 2021.
Performance
PCRX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total debt Formula
Total Debt = Short Term Debt + Long Term Debt
PCRX Total debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +9.0% | +9.4% |
3 y3 years | -43.4% | -36.4% |
5 y5 years | +81.5% | +79.7% |
PCRX Total debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -43.4% | +9.0% | -23.4% | +9.4% |
5 y | 5-year | -43.4% | +81.5% | -43.6% | +60.9% |
alltime | all time | -43.4% | >+9999.0% | -43.6% | >+9999.0% |
PCRX Total debt History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $636.46M(-0.4%) |
Dec 2024 | $638.85M(+9.0%) | $638.85M(-0.9%) |
Sep 2024 | - | $644.42M(-0.6%) |
Jun 2024 | - | $648.60M(+11.5%) |
Mar 2024 | - | $581.78M(-0.7%) |
Dec 2023 | $586.04M(-23.2%) | $586.04M(-0.7%) |
Sep 2023 | - | $590.30M(-4.9%) |
Jun 2023 | - | $620.71M(-0.7%) |
Mar 2023 | - | $625.16M(-18.1%) |
Dec 2022 | $763.39M(-32.4%) | $763.39M(-7.1%) |
Sep 2022 | - | $821.64M(-1.2%) |
Jun 2022 | - | $831.36M(-17.0%) |
Mar 2022 | - | $1.00B(-11.3%) |
Dec 2021 | $1.13B(+108.6%) | $1.13B(+103.6%) |
Sep 2021 | - | $554.56M(+1.0%) |
Jun 2021 | - | $549.27M(+0.9%) |
Mar 2021 | - | $544.15M(+0.6%) |
Dec 2020 | $541.13M(+53.8%) | $541.13M(+0.9%) |
Sep 2020 | - | $536.37M(+35.6%) |
Jun 2020 | - | $395.69M(+11.7%) |
Mar 2020 | - | $354.24M(+0.7%) |
Dec 2019 | $351.92M(+21.0%) | $351.92M(+1.7%) |
Sep 2019 | - | $346.01M(+0.8%) |
Jun 2019 | - | $343.40M(+4.3%) |
Mar 2019 | - | $329.24M(+13.2%) |
Dec 2018 | $290.93M(+5.2%) | $290.93M(+1.3%) |
Sep 2018 | - | $287.23M(+1.3%) |
Jun 2018 | - | $283.59M(+1.3%) |
Mar 2018 | - | $280.01M(+1.3%) |
Dec 2017 | $276.50M | $276.50M(+1.3%) |
Sep 2017 | - | $273.04M(+1.3%) |
Jun 2017 | - | $269.65M(+1.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2017 | - | $266.75M(+145.3%) |
Dec 2016 | $108.74M(+4.5%) | $108.74M(+1.1%) |
Sep 2016 | - | $107.56M(+1.1%) |
Jun 2016 | - | $106.39M(+1.1%) |
Mar 2016 | - | $105.22M(+1.1%) |
Dec 2015 | $104.04M(+0.9%) | $104.04M(-0.8%) |
Sep 2015 | - | $104.91M(+1.0%) |
Jun 2015 | - | $103.89M(-0.2%) |
Mar 2015 | - | $104.14M(+1.0%) |
Dec 2014 | $103.10M(+4.2%) | $103.10M(+1.0%) |
Sep 2014 | - | $102.06M(+1.0%) |
Jun 2014 | - | $101.03M(+1.0%) |
Mar 2014 | - | $100.00M(+1.0%) |
Dec 2013 | $98.96M(+292.8%) | $98.96M(+1.1%) |
Sep 2013 | - | $97.93M(+1.1%) |
Jun 2013 | - | $96.89M(+1.1%) |
Mar 2013 | - | $95.86M(+280.5%) |
Dec 2012 | $25.19M(-1.5%) | $25.19M(-5.5%) |
Sep 2012 | - | $26.65M(+8.0%) |
Jun 2012 | - | $24.67M(-10.8%) |
Mar 2012 | - | $27.66M(+8.1%) |
Dec 2011 | $25.58M(+2.1%) | $25.58M(+0.4%) |
Sep 2011 | - | $25.47M(-11.9%) |
Jun 2011 | - | $28.91M(+15.0%) |
Mar 2011 | - | $25.14M(+0.3%) |
Dec 2010 | $25.05M(>+9900.0%) | $25.05M(-54.9%) |
Sep 2010 | - | $55.55M(+887.5%) |
Jun 2010 | - | $5.63M(>+9900.0%) |
Mar 2010 | - | $0.00(0.0%) |
Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2009 | - | $0.00 |
Dec 2008 | $0.00 | - |
FAQ
- What is Pacira BioSciences annual total debt?
- What is the all time high annual total debt for Pacira BioSciences?
- What is Pacira BioSciences annual total debt year-on-year change?
- What is Pacira BioSciences quarterly total debt?
- What is the all time high quarterly total debt for Pacira BioSciences?
- What is Pacira BioSciences quarterly total debt year-on-year change?
What is Pacira BioSciences annual total debt?
The current annual total debt of PCRX is $638.85M
What is the all time high annual total debt for Pacira BioSciences?
Pacira BioSciences all-time high annual total debt is $1.13B
What is Pacira BioSciences annual total debt year-on-year change?
Over the past year, PCRX annual total debt has changed by +$52.81M (+9.01%)
What is Pacira BioSciences quarterly total debt?
The current quarterly total debt of PCRX is $636.46M
What is the all time high quarterly total debt for Pacira BioSciences?
Pacira BioSciences all-time high quarterly total debt is $1.13B
What is Pacira BioSciences quarterly total debt year-on-year change?
Over the past year, PCRX quarterly total debt has changed by +$54.68M (+9.40%)